Eric Pach, MBA, ACI, CRM, CIC, CRIS, MLIS
PHOENIX, Ariz. – Effective 2023, INSURICA’s Captive Leader Eric Pach has been appointed to the Board of Directors for the Arizona Builders Alliance (ABA).
“I am very humbled to represent the Arizona construction community as a member of the board,” Eric Pach said, “It’s amazing to see the impact and influence the ABA has on the development of talent, regulatory environment, and the collaborative construction culture we have here in Arizona and the Southwest.”
The ABA is an alliance of the Associated Builders & Contractors (ABC) and the Associated General Contractors of America – Building Chapter (AGC).
Eric Pach was one of the original founders of a new division of the ABA called the Young Builders Council (YBC), which started in 2016 and now has grown to more than 175 members, all under 40 years old.
“The Young Builders Council is critical to developing the next generation by providing access to top construction leaders, personal and professional development resources, and numerous networking opportunities,” Pach said.
ABA is an alliance of the Arizona Chapters of the Associated Builders & Contractors (ABC), and the Associated General Contractors of America – Building Chapter (AGC).
The ABA’s purpose is to lead its members and the construction industry to greater productivity and profitability through Education: Craft Training to Management Education, Networking and Business Development Opportunities and Legislative Advocacy on behalf of the Commercial Construction Industry.
About the Author
Share This Story
Related Blogs
RxDC Reporting: What Employers Should Do Before the June 1 Deadline
Each year, group health plans must report detailed prescription drug and healthcare spending data to the Centers for Medicare & Medicaid Services (CMS). This reporting—commonly referred to as RxDC reporting—is due by June 1 and applies to most employer-sponsored group health plans that offer prescription drug coverage.
Chronic Condition Management 2.0: GLP-1 Alternatives and New Digital Therapeutics
Chronic conditions have long been the primary driver of employer healthcare spending, but 2026 marks a turning point in how organizations are approaching prevention, treatment, and long-term management. With GLP-1 medications dominating headlines — and budgets — employers are urgently exploring complementary or alternative strategies that can improve outcomes without unsustainable cost growth. The result is a new wave of digital therapeutics, metabolic health programs, and integrated care models that promise a more balanced approach to chronic disease management.
The Return-to-Office Reset: How Benefits Are Being Re-Engineered in 2026
After several years of experimentation, many employers are tightening hybrid schedules or requiring more in-office days. This “return-to-office reset” is reshaping benefits strategies as organizations look for ways to support commuting employees, improve onsite experience, and maintain flexibility. What began as a workplace policy shift is now driving a broader rethinking of how benefits can reinforce culture, productivity, and retention.